Stay updated on ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page
- CheckyesterdayChange DetectedThe page footer now shows Revision: v3.6.6, replacing v3.6.5. This indicates a small update to the page template or backend without changes to the study details.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, indicating a small backend or frontend update to the study page without affecting its content.SummaryDifference0.1%

- Check36 days agoChange DetectedRevision: v3.6.4 has been added, replacing the prior Revision: v3.6.3. This indicates a software/template update for the page rather than a modification to the study data or displayed content.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page's release version was updated from v3.6.2 to v3.6.3, indicating a minor maintenance update to the ClinicalTrials.gov entry without changes to study data or eligibility.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page footer revision label was updated from v3.6.0 to v3.6.2, indicating a software update. This change does not modify the study details, eligibility criteria, or displayed information.SummaryDifference0.1%

- Check79 days agoChange DetectedNew help and navigation links were added to the page, including sections for checking who can join, finding contact information, how to read a study record, common questions, and how to join a study, along with a header formatting update for Intervention/Treatment; the site revision tag was updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

Stay in the know with updates to ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page.